Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 1Depressive Disorder, Major 1Cancer Pain 1Bipolar Disorder 1

Interventions

Pharmaceutical Services 2Lidocaine 2Ethanol 2Acetaminophen 2Venlafaxine Hydrochloride 1Ropivacaine 1Radiofrequency Ablation 1Pregabalin 1Oxycodone 1Myofascial Release Therapy 1Morphine 1Methadone 1Memantine 1Ketamine 1Hospitals 1Gels 1Dronabinol 1Cholecalciferol 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cancer Pain × Venlafaxine Hydrochloride × Clear all
NCT04737967 2021-02-04

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Mendel AI

Phase 2/3 Unknown
60 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡